Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-0543-2020

Drug recall · December 11, 2019

Regular Strength Zantac 75 mg recall

Why: CGMP Deviations: Presence of NDMA impurity detected in product.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 68151-2584-0.

Lots / codes

all lots

Company
Sanofi-Aventis U.S. LLC, Bridgewater, NJ
Distribution
Nationwide
Initiated
October 22, 2019 · Voluntary: Firm initiated
Classified
December 1, 2019
Reported
December 11, 2019
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.